APT(SH:688617) Sou Hu Cai Jing·2025-07-21 11:58Group 1 - The core viewpoint of the articles highlights the performance and valuation of Huatai Medical, which closed at 296.24 yuan with a PE ratio of 58.33 times, indicating a strong market position within the medical device industry [1][2] - Huatai Medical's total market capitalization is reported at 41.774 billion yuan, ranking 88th in the industry based on PE ratio, which has an average of 52.71 times and a median of 37.14 times [1][2] - As of the first quarter of 2025, 110 institutions hold shares in Huatai Medical, with a total of 18.3304 million shares valued at 5.444 billion yuan [1] Group 2 - The main business of Huatai Medical focuses on the research, production, and sales of electrophysiology and interventional medical devices, including products for electrophysiology, coronary pathways, peripheral vascular intervention, and non-vascular intervention [1] - The latest financial results for the first quarter of 2025 show that Huatai Medical achieved an operating income of 564 million yuan, representing a year-on-year increase of 23.93%, and a net profit of 183 million yuan, up 30.69%, with a gross profit margin of 73.09% [1]